Documented Customer Case Report

After Nearly 6 Years of Elevated Liver Enzymes, His AST and ALT Returned to Normal Range

A 51-year-old daily drinker with elevated liver markers across multiple lab panels from 2019 through 2025. Both markers returned to range in May 2026, during a period when his reported drinking routine stayed about the same.

CustomerChris, 51
Period2018 – 2026
Data source6 blood panels
PublishedJune 2026
Summary

Chris had elevated or borderline AST and ALT on nearly every comprehensive metabolic panel from late 2019 through 2025. Around September 2025, he began taking Cloud9 Daily Restore daily. He reports deliberately keeping his drinking routine constant, averaging 2+ drinks per day, to see whether anything changed. His May 2026 panel showed both markers within normal range. This is one documented customer case, not a clinical trial, and cannot establish causation.

ALT−49%69 high → 35, back in normal range
AST−43%40 → 23, within range
Daily use~9 moDaily Restore, before follow-up panel
Drinking routine2+/dayReported as unchanged throughout
01 · Background

Hoping the Next Test Wouldn’t Be Worse

Chris had been a casual drinker for years. His December 2018 labs were clean: AST 29, ALT 49, both within range.

In 2019, his routine changed. He started working from home, and working from home created more opportunity to drink. Over time, he became a daily drinker averaging at least two drinks per day.

His bloodwork changed with him. By November 2019, his ALT had nearly doubled to 95. Both markers flagged high, and they stayed elevated on panel after panel for years.

His doctor recommended cutting back. Chris understood the advice. He just couldn’t sustain it.

“I knew what was needed. But after multiple attempts to cut back, which I would be able to do for a few days, things would always go back to normal. I would just hope that the next tests wouldn’t be worse than the last.”
Chris, on the years before the follow-up panel
02 · Lab History

Elevated on Every Panel

Six comprehensive metabolic panels spanning December 2018 to May 2026. ALT was flagged high on every panel from late 2019 through 2025, then returned to normal in May 2026. The charts below use a true time scale, so the gap between panels is shown proportionally.

ALT · Alanine Aminotransferase (U/L)

Shaded zone indicates elevated territory. Gold dashed line marks Daily Restore start, Sept 2025.
25 50 75 100 ULN 63 U/L Daily Restore 49 95 92 66 69 35 2019 2020 2021 2022 2023 2024 2025 2026

AST · Aspartate Aminotransferase (U/L)

Same panels, same timeline.
15 30 45 60 ULN 40 U/L Daily Restore 29 50 46 40 40 23 2019 2020 2021 2022 2023 2024 2025 2026
Flagged high Within range Upper limit of normal, 2018–2021 lab range (later ranges varied; see note) Daily Restore start · Sept 2025
Date AST ALT Result
Dec 2018 29 49 Within range
Nov 2019 50 95 AST + ALT high
Jan 2020 46 92 AST + ALT high
Jan 2021 40 66 ALT high
May 2025 40 69 ALT high
May 2026 23 35 Within range

All values in U/L, from customer-provided comprehensive metabolic panels collected Dec 5, 2018; Nov 25, 2019; Jan 10, 2020; Jan 5, 2021; May 22, 2025; and May 13, 2026 at two accredited hospital lab systems. Reference ranges varied by panel: ALT upper limit 63 (2018–2021), 50 (2025), 64 (2026); AST upper limit 40 (2018–2021), 50 (2025), 37 (2026). Flags shown are from the original lab reports. Chris’s May 2026 AST and ALT are within range under every reference range used across all six panels.

03 · What Changed

One Change. Everything Else Stayed the Same.

Chris started Cloud9 Daily Restore around September 2025 and took it every day. It was his first liver health supplement. He was skeptical, so he set up his own informal test: hold the rest of his routine constant and see what the next labs said.

That meant his drinking stayed where it was, at 2+ drinks per day on average. He noticed he felt less urge to drink during this period, but his actual habits held steady.

Held constant

Drinking routine

2+ drinks per day on average. Reported as “almost exactly the same” for the full nine months.

Avg drinks/day No change Sept 2025 May 2026
Added daily

Cloud9 Daily Restore

Started Sept 2025. Taken every day through the May 2026 follow-up panel and still in use.

Daily doses Taken daily Sept 2025 May 2026

This matters because most liver marker improvements follow a major lifestyle change: less alcohol, a new diet, weight loss, new medication. Here, the one variable Chris reports changing was Daily Restore.

“I knew I needed to do something. And I secretly knew that cutting back or stopping was not going to happen. I thought if it helped these people, I would give it a try.”
Chris, on starting Daily Restore
04 · Follow-Up Results

May 2026: “All Normal”

Nine months after starting Daily Restore, his comprehensive metabolic panel came back. ALT, elevated on panel after panel since 2019, was within normal range. AST dropped by nearly half. His doctor’s message after reviewing the results was two words: “All normal.”

Marker May 2025 May 2026 Change
ALT 69 High 35 Normal −49%
AST 40 23 Normal −43%
“Shock that even though I didn’t change my drinking habits, my enzymes showed as normal again. That’s something I didn’t think would ever happen.”
Chris, on seeing the May 2026 results

After years of bracing for each new test, the pattern had finally broken. And it broke in the bloodwork, not just in how he felt.

05 · The Full Sequence

The Full Lab Record: Dec 2018 to May 2026

  • Dec 2018
    Clean baseline

    AST 29, ALT 49. Both within range.

  • 2019
    The routine shifts

    Work-from-home begins. Daily drinking becomes the norm. By November, ALT hits 95 and both markers flag high.

  • 2020 – 2025
    Years of elevated panels

    ALT stays above range on panel after panel. Attempts to cut back last a few days. The anxiety before each test becomes routine.

  • Sept 2025
    Daily Restore, every day

    Chris starts Daily Restore and deliberately keeps his drinking routine constant to see if anything changes.

  • May 2026
    “All normal”

    ALT 35, AST 23. Both within range for the first time in nearly six years.

06 · Limitations

What This Case Can and Cannot Show

This is one documented customer case, not a clinical trial. Liver enzymes can change for many reasons, and a single case cannot establish causation.

The May 2026 panel was processed by a different lab than the earlier panels, with slightly different reference ranges. This does not change the conclusion: his final AST and ALT values are within range under every reference range used by either lab across all six panels, and his elevated values were flagged high under the ranges in effect when they were drawn.

This case can show

  • A documented multi-year lab trend
  • A real customer-reported timeline
  • Roughly nine months of consistent Daily Restore use
  • A reported drinking routine that stayed about the same

This case cannot show

  • Clinical proof
  • Guaranteed results
  • Causation
  • A replacement for reducing alcohol

Daily Restore is currently being evaluated in an independent participant-based clinical trial measuring liver function, mood, sleep, energy, and recovery.

07 · Discussion

The Gap Between Knowing and Changing

Chris’s story is the story of a lot of regular drinkers. The doctor says cut back. You understand. You try. You manage it for a few days, and then your normal routine comes back. Knowing you should change is not the same as being able to change overnight.

For Chris, nine months of consistent Daily Restore use coincided with something he had not seen in nearly six years: normal liver enzymes.

“If my story can help just one other person, I’m more than happy to help.”
Chris
About the product in this report

Cloud9 Daily Restore

Daily Restore is a clinician-developed daily supplement for adults who drink and want to support the systems alcohol can stress, including the liver. It is not a cure, a treatment, or a replacement for reducing alcohol.

Learn about Daily Restore →

Individual results vary. This page describes one documented customer experience and is not a guarantee of results. Customer name used with permission. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.